Relative Bioavailability and Food Effect Study for GSK163090 in Healthy Male and Female Volunteers
Status:
Completed
Trial end date:
2007-11-05
Target enrollment:
Participant gender:
Summary
The study will consist of a screening period, 3 treatment periods and a post-treatment
follow-up. In each of the 3 treatment periods, subjects will receive a single oral dose of
GSK163090 in the fed or fasted state, followed by a 7-day wash-out period between each dose